Bionano announces publication of interim readout from clinical trial run by consortium analyzing optical genome mapping as potential standard of care for prenatal testing

Irb-approved, multi-site, ongoing study evaluated 200 samples representing 123 unique prenatal cases across 9 sites for interim measures of key endpoints:

BNGO Ratings Summary

BNGO Quant Ranking